Replacement and dialysate fluids for patients with acute renal failure treated by continuous veno-venous haemofiltration and/or haemodiafiltration

Contributions to Nephrology

Volumn 144, Issue , 2004, Pages 317-328

  Davenport, Andrew ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CITRIC ACID; DIALYSIS FLUID; ELECTROLYTE;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; CHEMISTRY; CRITICAL ILLNESS; DISINFECTION; HEMODIAFILTRATION; HEMOFILTRATION; HUMAN; REVIEW; TEMPERATURE;

ACID-BASE EQUILIBRIUM; ANTICOAGULANTS; CITRATES; CRITICAL ILLNESS; DIALYSIS SOLUTIONS; DISINFECTION; ELECTROLYTES; HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; TEMPERATURE;

EID: 3342978166     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000078899     Document Type: Article

References (32)

1. Kramer P, Wigger W, Rieger J, Mathaei D, Scheler F: Arteriovenous hemofiltration: A new and simple method for the treatment of over hydrated patients resistant to diuretics. Klin Wochenschr 1977;5:1121-1122.
2. Ronco C, Bellomo R, Hamel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure. Lancet 2000;356:26-30.
3. Grootendorst AF, van Saase JLCM: Blood purification by hemofiltration in septic shock and multiple organ dysfunction syndrome patients; in Bellomo R, Ronco C (eds): Update in Intensive Care and Emergency Medicine. Heidelberg, Springer-Verlag, 1995, vol 20, pp 311-325.
4. Davenport A: Peritoneal host defence in patients with end-stage renal failure treated by peritoneal dialysis; in Sweny P, Rubin R, Tolkoff-Rubin N (eds): The Infectious Complications of Renal Disease. Oxford, Oxford University Press, 2003, pp 41-68.
5. The EBPG Expert Group on Haemodialysis: European Best Practice Guidelines for haemodialysis. Part 1; section IV Dialysis fluid purity. Nephrol Dial Transplant 2002;17(suppl 7):45-62.
6. Ministère de l'Emploi et de la Solidarieté: Circulaire relative aux specifications techniques de la securitié de pratique de I'hémofiltration et de I'hémodiafiltration en ligne dans établissements de santé. Republique Française, Circulaire DGS/DH/AFSSAPS no 311, June 7, 2000.
7. Schindler R: Passage of LPS and non-LPS like cytokine inducing substances across synthetic dialyzer membranes. Blood Purif 2003;21:343-344.
8. Morimatsu H, Uchino S, Bellomo R, Ronco C: Continuous renal replacement therapy: Does technique influence electrolyte and bicarbonate control? Int J Artif Organs 2003;26:289-296.
9. Uchino S, Cole L, Morimatsu H, Goldsmith D, Ronco C, Bellomo R: Solute mass balance during isovolemic high volume hemofiltration. Intens Care Med 2003;9:1541-1546.
10. Lindsay RM, Leitch R, Heidenheim AP, Kortas C: Daily short hours and long slow nocturnal hemodialysis: The London, Ontario study. Blood Purif 2003;21:335-340.
11. Davenport A: Hemofiltration in patients with fulminant hepatic failure. Lancet 1991;338:1604.
12. Davenport A, Kirby SA: Hemofiltration/dialysis treatment in patients with acute renal failure. Care Crit Ill 1996;12:54-58.
13. Veech RL: The untoward effects on anions of dialysis fluids. Kid Int 1991;34:587-589.
14. Katzarski KS: Fluid state and blood pressure control in patients on maintenance hemodialysis, MD thesis, Stockholm, 1999.
15. Wright DA, Forni LG, Carr LG, Treacher DF, Hilton PJ: Use of continuous hemofiltration assess the rate of lactate metabolism in acute renal failure. Clin Sci 1996;90:507-510.
16. Davenport A, Will EJ, Davison AM: Hyperlactatemia and metabolic acidosis during hemofiltration using lactate buffered fluids. Nephron 1991;59:461-465.
17. Nimmo GR, Grant IS, Mackenzie SJ: Lactate and acid base changes in the critically ill. Post-Grad Med J 1991;67(suppl 1):S56-S61.
18. Davenport A, Worth DP, Will EJ: Hypochloremic alkalosis after high flux continuous hemofiltration and continuous arterio-venous hemofiltration with dialysis. Lancet 1988;i:658.
19. Cole L, Bellomo R, Baldwin I, Hayhoe M, Ronco C: The impact of lactate buffered high-volume hemofiltration on acid-base balance. Intens Care Med 2003;7:1113-1120.
20. Thomas AN, Guy JM, Kishen R, Bowles BMJ, Vadgama P: Comparison of lactate and bicarbonate buffered hemofiltration fluids: Use in critically ill patients. Nephrol Dial Transplant 1997;12:1212-1217.
21. Heering P, Ivens K, Thümer O, Moergera S, Heintzen M, Passlick-Deetjen J, Willers R, Strauber BE, Grabenensee B: The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure. Intens Care Med 1999;25:1244-1251.
22. Zimmerman D, Cotman P, Ting R, Karanicolas S, Tobe SW: Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: Prospective cross-over comparison with a lactate buffered solution. Nephrol Dial Transplant 1999;14:2387-2391.
23. MacLean AG, Davenport A, Cox D, Sweny P: Effects of continuous haemodiafiltration against lactate buffered and lactate-free dialysate in patients with, and without liver dysfunction. Kid Int 2000;58:1765-1772.
24. Kierdorf HP, Leue C, Arns S: Lactate or bicarbonate buffered solutions in continuous extracorporeal renal replacement therapies. Kid Int 1999;56(suppl 72):S32-S36.
25. Goldsmith DJA, Forni LG, Hilton PJ: Bicarbonate therapy and intracellular acidosis. Clin Sci 1997;93:593-598.
26. Mehta RL, McDonald BR, Aguilar MM, Ward DM: Regional citrate anticoagulation for continuous arterio-venous hemodialysis in critically ill patients. Kid Int 1990;38:976-981.
27. Kutsogiannis DJ, Mayers I, Chi WD, Gibney RT: Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kid Dis 2000;35:802-811.
28. Palson R, Niles JL: Regional citrate anticoagulation in continuous veno-venous hemofiltration in critically ill patients with a high risk of bleeding. Kid Int 1999;55:1991-1997.
29. Bunchman T, Maxvold NJ, Barnett J, Hutchings A, Benfield MR: Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol 2002;17:150-154.
30. Davenport A: Dialysate and substitution fluids for patients treated by continuous forms of renal replacement therapy (CCRT). Contrib Nephrol. Basel, Karger, 2001, vol 132, pp 313-322.
31. Nowak MA, Campbell TE: Profound hypercalcaemia in continuous veno-venous hemofiltration dialysis with trisodium citrate anticoagulation and hepatic failure. Clin Chem 1997;43:412-4l3.
32. Yagi N, LeBlanc M, Sakai K, Wright EJ, Paganini EP: Cooling effect of continuous renal replacement therapies in critically ill patients. Am J Kid Dis 1999;32:1023-1030.